VMY-1-103
A novel dansylated analog of purvalanol B, and a CDK inhibitor that inhibits cell cycle progression and proliferation in prostate and breast cancer cells more effectively than purvalanol B.
Product Specifications
CAS Number
1209002-43-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
708.27
Molecular Formula
C34H42ClN9O4S
Notes
Research use only, not for human use.
Receptor
CDK
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6354261-01 0.2 mL
TBX6, ID (W158) (TBX6, T-box transcription factor TBX6) (APC)
Sign In for Pricing
View Details 
MBS6354261-02 5x 0.2 mL
TBX6, ID (W158) (TBX6, T-box transcription factor TBX6) (APC)
Sign In for Pricing
View Details MBS7018485-01 0.02 mg
Recombinant Escherichia coli O6:K15:H31 Prolipoprotein diacylglyceryl transferase (lgt)
Sign In for Pricing
View Details MBS7018485-02 0.1 mg
Recombinant Escherichia coli O6:K15:H31 Prolipoprotein diacylglyceryl transferase (lgt)
Sign In for Pricing
View Details MBS7018485-03 5x 0.1 mg
Recombinant Escherichia coli O6:K15:H31 Prolipoprotein diacylglyceryl transferase (lgt)
Sign In for Pricing
View Details